scholarly journals The Future State of Newborn Stem Cell Banking

2019 ◽  
Vol 8 (1) ◽  
pp. 117 ◽  
Author(s):  
Katherine Brown ◽  
Mahendra Rao ◽  
Heather Brown
Keyword(s):  
Stem Cells ◽  
Stem Cell ◽  
Personalized Medicine ◽  
Blood Banks ◽  
Cell Banking ◽  
The Future ◽  
Future Potential ◽  
Stem Cell Banking ◽  
Cord Blood Banks ◽  
And Personalized Medicine

Newborn stem cell banking began with the establishment of cord blood banks more than 25 years ago. Over the course of nearly three decades, there has been considerable evolution in the clinical application of stem cells isolated from newborn tissues. The industry now finds itself at an inflection point as personalized medicine and regenerative medicine continue to advance. In this review, we summarize our perspective on newborn stem cell banking in the context of the future potential that stem cells from perinatal tissues are likely to play in nascent applications. Specifically, we describe the relevance of newborn stem cell banking and how the cells stored can be utilized as starting material for the next generation of advanced cellular therapies and personalized medicine.

scholarly journals UMBILICAL CORD BLOOD BANKING IN THE WORLDWIDE HEMATOPOIETIC STEM CELL TRANSPLANTATION SYSTEM: PERSPECTIVES FOR UKRAINE

2017 ◽  
Vol 39 (3) ◽  
pp. 164-170 ◽  
Author(s):  
T O Kalynychenko
Keyword(s):  
Stem Cells ◽  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Cord Blood ◽  
Umbilical Cord ◽  
Umbilical Cord Blood ◽  
Hematopoietic Stem ◽  
Blood Banks ◽  
Cord Blood Banks

Significant progress in the promotion of procedural technologies associated with the transplantation of hematopoietic stem cells caused a rapid increase in activity. The exchange of hematopoietic stem cells for unrelated donor transplantations is now much easier due to the relevant international professional structures and organizations established to support cooperation and standard setting, as well as rules for the functioning of both national donor registries and cord blood banks. These processes are increasing every year and are contributing to the outpacing rates of development in this area. Products within their country should be regulated by the competent government authorities. This study analyzes the work of international and national levels of support for transplantation activity in the field of unrelated hematopoietic stem cell transplantation, the standardization order of technologies, as well as data that justify the need to create a network of donated umbilical cord blood banks in Ukraine as a factor in the development of allogeneic transplantation. This will promote the accessibility of international standards for the treatment of serious diseases for Ukrainian citizens.

Perinatal Stem Cells Isolated From Complete Umbilical Cord Tissue for Family Stem Cell Banking and Potential Therapeutic Use

2018 ◽  
pp. 257-269
Author(s):  
Robert Briddell ◽  
Frank Litkenhaus ◽  
James E. Carroll ◽  
Mohammed Ali ◽  
Kate F. Girard ◽  
...  
Keyword(s):  
Stem Cells ◽  
Stem Cell ◽  
Umbilical Cord ◽  
Therapeutic Use ◽  
Cell Banking ◽  
Umbilical Cord Tissue ◽  
Stem Cell Banking

scholarly journals Knowledge and Attitude Among Lebanese Pregnant Women Toward Cord Blood Stem Cell Storage and Donation

Medicina ◽  
2019 ◽  
Vol 55 (6) ◽  
pp. 244
Author(s):  
Fatima A. Saleh
Keyword(s):  
Stem Cells ◽  
Stem Cell ◽  
Cord Blood ◽  
Pregnant Women ◽  
Adult Stem Cells ◽  
Blood Stem Cell ◽  
Cord Blood Stem Cell ◽  
Cell Banking ◽  
Knowledge And Attitude ◽  
Stem Cell Banking

Background: Umbilical cord blood (UCB) used to be considered waste material and was discarded at birth. However, cord blood is now considered a rich source of adult stem cells that can be used to treat many conditions and diseases. This study was performed to determine pregnant women’s knowledge and attitudes toward cord blood stem cell banking and donation in Lebanon. Methods: A descriptive study was conducted in antenatal clinics in Beirut and data were collected using a questionnaire distributed to pregnant women after provision of informed consent. A total of 244 women responded. Results: Less than half of the women (46%) reported knowledge about cord blood banking. However, participants with university and secondary education had significantly higher odds of considering UCB storage compared to those with primary education (odds ratio (OR) 8.62, 95% confidence interval (CI) 2.74–27.15 and OR 21.23,95% CI 6.55–68.86, respectively). Older pregnant women were less likely to think about UCB stem cells storage (OR 0.92, 95% CI 0.85–0.98). Conclusion: Respondents who had an existing knowledge about UCB stem cells banking in general were more likely to consider storing UCB in blood banks if affordable (45.9%). Therefore, it is necessary to inform pregnant women about stem cell banking so that they can make the appropriate decisions for themselves.

scholarly journals Stem cell drugs: the next generation of pharmaceutical products

2016 ◽  
Vol 3 (10) ◽  
pp. 857 ◽  
Author(s):  
Phuc Van Pham
Keyword(s):  
Stem Cells ◽  
Stem Cell ◽  
Personalized Medicine ◽  
Regenerative Medicine ◽  
Pharmaceutical Products ◽  
Patient Needs ◽  
Disease Treatment ◽  
New Treatment ◽  
And Personalized Medicine ◽  
Live Stem Cell

Stem cells represent a new treatment option in medicine and pharmacy. Stem cells have been increasingly used for the treatment of many diseases. In fact, they have spurred a new age of medicine called regenerative medicine. In recent years, regenerative medicine has become a new revolution in disease treatment, especially with the use of stem cell drugs. Stem cell drugs refer to live stem cell based products that used as drugs for particular diseases. Unlike autologous stem cell transplantation, stem cell drugs are “off-the-shelf” products that are ready to be used without requirement of any further manipulation. This review aims to summarize some of the approved stem cell drugs, and discuss the revolution of regenerative medicine and personalized medicine. As well, the review will discuss how stem cell drugs have led to a new direction in stem cell therapy, providing a new platform for patient needs.

The future of glioma treatment: stem cells, nanotechnology and personalized medicine

2012 ◽  
Vol 8 (9) ◽  
pp. 1149-1156 ◽  
Author(s):  
Maryam Rahman ◽  
Brian Hoh ◽  
Nathan Kohler ◽  
Erin M Dunbar ◽  
Gregory JA Murad
Keyword(s):  
Stem Cells ◽  
Personalized Medicine ◽  
The Future ◽  
And Personalized Medicine
Sign in / Sign up

Export Citation Format

Share Document